Literature DB >> 27565986

Risk factors for silent myocardial ischemia in patients with well-controlled essential hypertension.

Domenico Rendina1,2, Renato Ippolito3, Gianpaolo De Filippo3,4, Riccardo Muscariello3, Daniela De Palma3, Silvana De Bonis5,6, Michele Schiano di Cola3, Domenico Benvenuto5, Maurizio Galderisi7, Pasquale Strazzullo3, Ferruccio Galletti3.   

Abstract

Silent myocardial ischemia (SMI) is frequently observed in patients with essential hypertension (EH). The major risk factor for SMI is uncontrolled blood pressure (BP), but SMI is also observed in patients with well-controlled BP. To evaluate the prevalence of SMI and the factors associated with SMI in EH patients with well-controlled BP. The medical records of 859 EH patients who underwent simultaneous 24-h ambulatory blood pressure monitoring (ABPM) and 24-h ambulatory electrocardiogram recording (AECG) were retrospectively evaluated. Each SMI episode was characterized by: (a) ST segment depression ≥0.5 mm; (b) duration of ST segment depression >60 s; and (c) reversibility of the ST segment depression. Overall 126 EH patients (14.7 %) had at least one episode of SMI. The SMI events were more frequent among patients with poorly controlled compared to those with well-controlled BP [86/479 (17.95 %) vs. 40/380 (10.52 %), p < 0.01]. Among EH patients with well-controlled BP, current and past smoking as well as the presence of an additional metabolic syndrome (MetS) constitutive element (obesity, impaired fasting glucose level or dyslipidemia) were significantly associated with the occurrence of SMI. In all EH patients with well-controlled BP and AECG evidence of SMI, there were one or more coronary artery stenotic lesions greater than 50 % found at coronary angiography. In EH patients who are current smokers, or have one or more additional components of a MetS there is markedly reduced benefit associated with good BP control with regard to the occurrence of myocardial ischemia: in this patient category, an AECG may help detect this condition.

Entities:  

Keywords:  24-h ambulatory blood pressure monitoring; 24-h ambulatory electrocardiogram; Asymptomatic coronary artery disease; Blood pressure control

Mesh:

Year:  2016        PMID: 27565986     DOI: 10.1007/s11739-016-1527-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  53 in total

1.  ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography: A report of the ACC/AHA/ACP-ASIM task force on clinical competence (ACC/AHA Committee to develop a clinical competence statement on electrocardiography and ambulatory electrocardiography) endorsed by the International Society for Holter and noninvasive electrocardiology.

Authors:  A H Kadish; A E Buxton; H L Kennedy; B P Knight; J W Mason; C D Schuger; C M Tracy; W L Winters; A W Boone; M Elnicki; J W Hirshfeld; B H Lorell; G P Rodgers; C M Tracy; H H Weitz
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

Review 2.  Silent ischemia: clinical relevance.

Authors:  C Richard Conti; Anthony A Bavry; John W Petersen
Journal:  J Am Coll Cardiol       Date:  2012-01-31       Impact factor: 24.094

Review 3.  Silent ischaemia and hypertension.

Authors:  D Boon; J J Piek; G A van Montfrans
Journal:  J Hypertens       Date:  2000-10       Impact factor: 4.844

4.  Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement.

Authors:  G F Mitchell; L A Moyé; E Braunwald; J L Rouleau; V Bernstein; E M Geltman; G C Flaker; M A Pfeffer
Journal:  Circulation       Date:  1997-12-16       Impact factor: 29.690

5.  Prevalence of episodes of ST-segment depression among mild-to-moderate hypertensive patients in northern Italy: the Cardioscreening Study.

Authors:  M Stramba-Badiale; O Bonazzi; G Casadei; C Dal Palù; B Magnani; A Zanchetti
Journal:  J Hypertens       Date:  1998-05       Impact factor: 4.844

6.  Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity.

Authors:  J A Panza; S E Epstein; A A Quyyumi
Journal:  N Engl J Med       Date:  1991-10-03       Impact factor: 91.245

7.  Circadian variation of transient myocardial ischemia in patients with coronary artery disease.

Authors:  M B Rocco; J Barry; S Campbell; E Nabel; E F Cook; L Goldman; A P Selwyn
Journal:  Circulation       Date:  1987-02       Impact factor: 29.690

8.  Silent myocardial ischemia and infarction: insights from the Framingham Study.

Authors:  W B Kannel
Journal:  Cardiol Clin       Date:  1986-11       Impact factor: 2.213

9.  Prevalence and circadian variations of ST-segment depression and its concomitant blood pressure changes in asymptomatic systemic hypertension.

Authors:  R Asmar; A Benetos; B Pannier; E Agnes; J Topouchian; B Laloux; M Safar
Journal:  Am J Cardiol       Date:  1996-02-15       Impact factor: 2.778

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  2 in total

Review 1.  The benefit of angiotensin AT1 receptor blockers for early treatment of hypertensive patients.

Authors:  Bruno Trimarco; Ciro Santoro; Marco Pepe; Maurizio Galderisi
Journal:  Intern Emerg Med       Date:  2017-08-02       Impact factor: 3.397

2.  Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome.

Authors:  Giovanni Cioffi; Ombretta Viapiana; Luigi Tarantini; Giovanni Orsolini; Luca Idolazzi; Federica Ognibeni Sonographer; Andrea Dalbeni; Davide Gatti; Angelo Fassio; Maurizio Rossini; Alessandro Giollo
Journal:  Intern Emerg Med       Date:  2020-10-20       Impact factor: 3.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.